logo
BMW and Mercedes outsold in China by an automaker you've never heard of

BMW and Mercedes outsold in China by an automaker you've never heard of

A Chinese electric vehicle brand has overtaken longtime market leaders BMW and Mercedes-Benz at the top of the world's biggest auto market.
Aito, an EV brand launched by Seres Group and tech giant Huawei, topped China's high-end car sales last year with 151,000 units delivered — surpassing BMW's 145,000 and Mercedes-Benz's 127,000, according to data from Shanghai-based consultancy ThinkerCar.
Aito's rise is largely due to the success of its flagship M9, a luxury SUV that went on sale in late 2023.
The M9 quickly proved popular with Chinese drivers thanks to its tech-heavy features, including Huawei's HarmonyOS operating system, a triple-screen dashboard, and premium interior options.
Seres, previously known for low-cost minivans under its DFSK Motor brand, repositioned itself with the Aito brand after forming a strategic partnership with Huawei in 2021.
Since then, rapid growth has resulted. Vehicle sales tripled over three years to about 427,000 units last year, and its stock rose by 120% on the Shanghai exchange over the same period.
Aito's success reflects a major shift in China's premium auto segment, which was once dominated by foreign brands. In 2020, Mercedes-Benz was top with 259,000 sales, followed by BMW on 235,000 and Porsche on 79,000, per ThinkerCar data.
By 2024, Chinese EV makers such as Aito and NIO had broken into the rankings, disrupting what ThinkerCar described as a BMW, Benz, and Audi "monopoly."
Sales of Chinese EVs are also rising outside their home market.
BYD outsold Tesla in Europe for the first time in April, according to JATO Dynamics data released on Thursday.
BYD also outsold Tesla globally in the first three months of the year, selling about 416,000 EVs, compared with Tesla's 336,700 EVs.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

It was not right – Max Verstappen takes blame for crash with George Russell
It was not right – Max Verstappen takes blame for crash with George Russell

Yahoo

time4 minutes ago

  • Yahoo

It was not right – Max Verstappen takes blame for crash with George Russell

Max Verstappen has issued a veiled apology for his wild crash with George Russell by admitting it 'was not right and should have not happened'. The four-time world champion was hit with a 10-second penalty by the stewards for causing a collision with Russell with two laps remaining of Sunday's Spanish Grand Prix. Advertisement Russell said he felt Verstappen's move was deliberate and accused the Red Bull driver of letting himself down. He also suggested that Verstappen should have been disqualified for the crash. Verstappen refused to accept blame for the coming together after the race and even sarcastically offered Russell a tissue after he was informed of his British rival's criticism. However, in a message posted on social media on Monday, Verstappen said: 'We had an exciting strategy and good race in Barcelona, till the safety car came out. 'Our tyre choice to the end and some moves after the safety car restart fuelled my frustration, leading to a move that was not right and shouldn't have happened. Advertisement 'I always give everything out there for the team and emotions can run high. You win some together, you lose some together. See you (at the next race) in Montreal.' Verstappen, who was on the slower hard tyre compound, lost third place to Charles Leclerc after he opened the door to the Ferrari driver when he made a mistake on the exit of the final corner in a six-lap shootout to the flag following the deployment of a safety car. Russell then attempted to sling his Mercedes underneath Verstappen's Red Bull at the first corner before the Dutchman took to the escape road and remained ahead of the Briton. Advertisement 'Max, can you let Russell through, please?' said Verstappen's race engineer, Gianpiero Lambiase. 'What? I was ahead, mate. What the f***! He just ran me off the road.' Verstappen slowed down at turn five to allow Russell past, but then accelerated and drove into his rival's Mercedes. 'What the f***'?' Russell said on the radio. Verstappen later moved out of Russell's way and crossed the line in fifth. However, he was hit with a timed penalty by the stewards – demoting him to 10th – and also punished with three penalty points on his licence which leaves him just one point away from a race ban. He now trails championship leader Oscar Piastri by 49 points in the standings. Mercedes' George Russell said he felt Max Verstappen's move was 'deliberate' (Bradley Collyer/PA) It marked another controversial chapter in Verstappen's career following run-ins last year with Lando Norris and multiple clashes with Lewis Hamilton in their title duel four years ago. Advertisement Mercedes team principal Toto Wolff, who has been linked with a move for Verstappen, said: 'I don't know exactly what the motivations were and I don't want to jump on it and say it was road rage, but it wasn't nice. 'The great ones, whether it's in motor racing or in other sports, you just need to have the world against you and perform at the highest possible level. 'That's why sometimes these greats don't recognise that actually the world is not against you, it's just you who has made a mistake or screwed up.'

Is Beaten-Down Summit Therapeutics Stock a Bad-News Buy?
Is Beaten-Down Summit Therapeutics Stock a Bad-News Buy?

Yahoo

time6 minutes ago

  • Yahoo

Is Beaten-Down Summit Therapeutics Stock a Bad-News Buy?

Summit Therapeutics stock fell hard recently in response to disappointing clinical trial results. Ivonescimab failed to produced a statistically significant overall survival benefit in the phase 3 Harmoni trial. Ivonescimab has been approved by Chinese regulators, but Summit Therapeutics has a license to sell it outside of China. 10 stocks we like better than Summit Therapeutics › Shares of Summit Therapeutics (NASDAQ: SMMT) tanked more than 30% on Friday, May 30. Such dramatic price swings aren't unusual in the biotechnology industry; in this case, disappointing data from an important clinical trial drove the stock down. Stock markets have a tendency to sell first and ask questions later. After watching this stock plummet, some bargain-shoppers are wondering if it fell too far. Recent trial results missed the mark the company was hoping for, but the results weren't entirely discouraging. Let's weigh the bad news against the good to see if this stock could be a beaten-down bargain. Summit Therapeutics and its investors have been eagerly anticipating results from the phase 3 Harmoni trial of ivonescimab. It's a bispecific antibody that works like a compination of Keytruda (a PD-1 inhibitor) plus Avastin (a VEGF inhibitor). Summit's stock price rocketed higher in 2024 thanks to Harmoni-2 trial results that showed it outperformed Keytruda at limiting tumor growth in lung cancer patients. Although ivonescimab is already approved in China, it's not for sale in the U.S. and EU, where Summit Therapeutics has a license to sell it. The Harmoni trial enrolled second-line lung cancer patients and treated them with ivonescimab or a placebo plus standard chemo. The treatment reduced the risk of disease progression in terms of tumor growth by 48%, but failed to show a convincing overall survival benefit. Adding ivonescimab to standard chemo reduced patients' risk of death by 21%, but the results fell just outside a 95% confidence interval with a p-value of 0.057. It's highly unlikely the Food and Drug Administration will approve ivonescimab for sale in the U.S. based on the Harmoni trial results. According to Summit, the FDA has been clear about the need for a statistically significant overall survival benefit to support an application. The China-based company that owns ivonescimab, Akeso, recently earned a second approval to market the therapy to lung cancer patients in China. Keytruda sales rose to $29.5 billion last year, and a treatment that can outperform the leader could do even better. Ivonescimab is unlikely to earn approval in the U.S. for patients similar to those enrolled in the Harmoni trial. Given its ability to shrink tumors, though, it's probably just a matter of time before it produces statistically significant overall survival results for an underserved patient population. Tumor responses get attention, but oncologists are far more interested in giving patients a chance for long-term survival. Keytruda's a top seller now because it produced dramatic overall survival results, compared to the standard treatments of its time. The lack of convincing overall survival data so far for ivonescimab severely reduces the odds that it will go on to produce blockbuster sales in the places where Summit Therapeutics has a license to sell it. Despite the obvious challenges ahead, expectations are still sky-high. Drugmaker stocks tend to trade at mid-single-digit multiples of trailing annual sales. Summit has no sales, as ivonescimab is the only candidate in its pipeline. Despite the lack of options and an uncertain path forward, the stock finished May with a market cap above $13.5 billion. If ivonescimab goes on to produce sales anywhere near Keytruda's, investors who bought Summit Therapeutics at recent prices could reap enormous gains. Unfortunately, the Harmoni trial's failure to produce a convincing overall survival benefit suggests that future sales will be muted, even if the company can get it past the FDA. It's probably best to watch this story play out from a safe distance. Before you buy stock in Summit Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Summit Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $828,224!* Now, it's worth noting Stock Advisor's total average return is 979% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Summit Therapeutics. The Motley Fool has a disclosure policy. Is Beaten-Down Summit Therapeutics Stock a Bad-News Buy? was originally published by The Motley Fool Sign in to access your portfolio

PG&E restarts huge grid battery following Moss Landing fire next door
PG&E restarts huge grid battery following Moss Landing fire next door

Yahoo

time10 minutes ago

  • Yahoo

PG&E restarts huge grid battery following Moss Landing fire next door

One of the biggest grid batteries in California has resumed operations following the cataclysmic Moss Landing fire in January. The San Francisco Bay Area's power grid used to draw on two battery storage plants in the quiet seaside town of Moss Landing. Texas-based power company Vistra built the nation's largest standalone grid battery on the grounds of an old gas power plant there, and utility Pacific Gas and Electric Co. built and owns the Elkhorn project next door. A roaring fire engulfed Vistra's historic turbine hall in January, wrecking rows of lithium-ion batteries that delivered 300 megawatts of instantaneous grid power. That site is still in shambles. PG&E's battery plant suffered far less disruption: Hot ash blew over the fenceline from Vistra's property, posing an environmental hazard and potentially clogging batteries' thermal management systems. But after several months of remediation, cleaning, and testing, PG&E was able to flip the switch Sunday to reconnect Elkhorn to the grid. That timing proved fortuitous, as it restored 182.5 megawatts/730 megawatt-hours of storage capacity into the power-hungry Silicon Valley grid corridor right before the region's first major heat wave of the summer. 'The concern was lower in the winter months, with demand lower,' said Dave Gabbard, vice president of power generation at PG&E. 'It will be critical to have assets like Elkhorn available as we get into the peak summer months.' Indeed, California has been building grid batteries at a record pace, to store the state's nation-leading solar generation and deliver it during crucial hours, like after sunset. The tech is displacing some gas-fired power generation in the state. California's battery fleet passed 15.7 gigawatts installed per a May tally, which Gov. Gavin Newsom's office touted as 'an unprecedented milestone.' The governor, a Democrat, did not specify why the 15.7-GW threshold merits particular attention, but it does mean California has added more than 5 GW since it crossed the 10-GW mark a year prior. 'The pace of construction for large-scale energy storage in California is phenomenal, the kind of accomplishment that was beyond our wildest dreams a few years ago,' said Scott Murtishaw, executive director of the California Energy Storage Alliance. The state's battery buildout is plowing ahead. But Vistra's fiery failure sparked deep community concerns about battery safety in California and beyond, as Moss Landing residents were forced to evacuate for several days and plumes of smoke loomed over surrounding estuaries and farmlands. In April, Vistra rescinded an application to build a 600-MW battery in Morro Bay, two hours down the coast from Moss Landing, following significant local resistance that intensified after the January fire. The reset at Elkhorn has rekindled concerns among community leaders who are still grappling with the fallout from the largest-ever battery fire in the U.S., and quite possibly the world. The Monterey County Board of Supervisors had asked to keep both battery plants offline until the Vistra investigation was completed and acted upon. 'Restarting operations before investigations are complete and before stronger emergency protocols are in place is disappointing and deeply troubling,' Monterey County Supervisor Glenn Church posted on Facebook after learning of PG&E's plans in early May. Crucially, PG&E's battery layout, completed in 2022, mitigates the hazards that took out the neighboring Vistra plant, which was completed two years earlier. Officials have not yet pinpointed the cause of Vistra's fire, but it became so destructive because it spread through the densely packed rows of batteries in the old turbine hall, igniting more and more fuel as it grew. By contrast, PG&E's Elkhorn plant spans 256 individual Tesla Megapack containers spaced over the property. 'We have a completely different design,' Gabbard said. 'We have compartmentalized our design so that fire propagation won't occur to adjacent units.' That industry-wide preference for separate, containerized systems doesn't eliminate the chance of battery fires, but it does limit the potential severity. One container might burn, but the fire can't reach all the other batteries. A fire could knock a facility offline temporarily, but it would only eliminate a small percentage of its capacity, Murtishaw said. That stands in contrast to Moss Landing's failure, or the all-or-nothing issues that can occur when a gas-burning turbine malfunctions. 'The technology and standards have changed considerably since the first big batteries,' like Vistra's, Murtishaw said. 'Facilities coming online now are being constructed with newer technologies meeting newer standards. Risk of runaway incidents has decreased dramatically relative to the amount of storage being deployed.' That compartmentalization strategy worked out when Elkhorn suffered its own battery fire in 2022 — the result of water seeping into a unit through an improperly installed roof, Gabbard said. The single unit burned in a contained fashion and did not spread to any other batteries. PG&E restarted the facility three months later, after implementing recommendations from an independent investigation into the cause. Since that incident, PG&E installed air quality monitoring onsite, and heat-sensing cameras that can automatically disconnect the site from the broader grid if they detect fire, Gabbard said. It also upgraded the battery enclosures to automatically discharge stored energy if abnormal behavior is detected. PG&E additionally updated its emergency action plan and instituted annual exercises with the North County Fire Protection District. When Vistra's plant burned up in January, the Elkhorn cameras spotted it and automatically severed the connection to the grid, halting the flow of high-voltage power out of the site. PG&E also made the air quality data available to emergency response teams. The utility then kept Elkhorn offline for the subsequent months to allow for environmental remediation of the soot to keep it out of local waterways, Gabbard said. Workers also cleaned the Megapacks 'outside and inside,' he noted. The main concern was that the ash could have intruded into the systems that cool batteries during operations. Staff pressure-washed all those components and tested their functionality to get the site ready for operations. Another 10 gigawatts of storage are already under contract for California's regulated utilities and community choice aggregators over the next four years, Murtishaw said. That would put the state over 25 gigawatts, well on its way to the current goal of 52 gigawatts by 2045, stemming from the state's clean energy law SB 100. To achieve that goal, the Moss Landing calamity needs to remain an outlier event. There's good reason to believe that will be the case. For one thing, the industry has all but abandoned Vistra's strategy of packing huge amounts of batteries into a single building. California now has 214 grid-scale batteries, and only about 10 of them reside in a building, Murtishaw noted. Those are subject to inspection by the California Public Utilities Commission under a recently expanded authority, he added; in the meantime, owners have stepped up safety measures in response to the Moss Landing news. Small-scale batteries in homes and businesses also count for California's top-line storage goal. They depend on the same core battery technologies as the large-scale storage projects, but as mass-produced consumer items, they go through a different gauntlet of tests before they reach customers. 'The home batteries are tested inside and out, up and down — they undergo rigorous safety testing and certification to standards,' said Brad Heavner, executive director of the California Solar and Storage Association, which advocates for rooftop solar and battery installers. In the state Legislature, Sen. John Laird, a Democrat from the Moss Landing area, introduced a bill in March to systematize coordination between battery owners and local emergency responders, and to fix a timing mismatch so California's fire codes match the latest standards set by the National Fire Protection Association. Murtishaw said the California Energy Storage Alliance supports the measure, which passed out of the Senate last week.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store